DUSP1 — Dual Specificity Phosphatase 1
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Dual Specificity Phosphatase 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DUSP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Dual Specificity Phosphatase 1</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>5q33.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1859](https://www.ncbi.nlm.nih.gov/gene/1859)</td></tr>
<tr><td><strong>OMIM</strong></td><td>603067</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000120129</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P28562](https://www.uniprot.org/uniprot/P28562)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Dual-specificity phosphatase</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">52 edges</a></td>
</tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
DUSP1 (Dual Specificity Phosphatase 1), also known as MKP1 (Mitogen-Activated Protein Kinase Phosphatase 1), is a critical negative regulator of MAPK signaling that dephosphorylates and inactivates MAPK family members including ERK, JNK, and p38["@avraham2022"]. DUSP1 is an immediate-early gene induced by cellular stress, growth factors, hormones, and neuronal activity["@keshet2021"]. It functions as a feedback phosphatase that provides tight control over MAPK signaling duration and intensity, preventing excessive or prolonged kinase activation that can lead to [cellular toxicity](/entities/apoptosis)[@yue2021].
In the central nervous system, DUSP1 plays essential roles in regulating [synaptic plasticity](/mechanisms/synaptic-plasticity), neuronal survival, and stress responses. Altered DUSP1 expression is observed in Alzheimer's disease (AD) and Parkinson's disease (PD), where it may represent a compensatory neuroprotective mechanism against dysregulated MAPK signaling["@kim2020"][@liu2022].
Molecular Function
Catalytic Activity
DUSP1 encodes a dual-specificity phosphatase belonging to the protein tyrosine phosphatase family. The enzyme possesses unique catalytic activity that allows it to dephosphorylate both phosphotyrosine and phosphothreonine/phosphoserine residues on MAP kinases[@roskoski2020]:
- ERK1/2 dephosphorylation: Inactivates ERK1/2 signaling, terminating proliferation and differentiation signals
- JNK dephosphorylation: Reduces stress-activated pro-apoptotic signaling
- p38 dephosphorylation: Dampens inflammatory and stress responses
Transcriptional Regulation
DUSP1 is transcriptionally induced by multiple stimuli:
- Stress signals: Oxidative stress, UV radiation, hypoxia
- Growth factors: NGF, BDNF
- Glucocorticoids: Cortisol-mediated neuroprotection
- Neuronal activity: Synaptic activity-dependent expression
This immediate-early gene response allows rapid feedback control of MAPK pathways[@petrulis2022].
Role in Neurodegeneration
Alzheimer's Disease
In AD brains, DUSP1 expression is significantly reduced in vulnerable brain regions[@hrdlickova2006]. This reduction contributes to:
Hyperactive MAPK signaling: Elevated p38 and JNK activity drives tau hyperphosphorylation and NFT formation[@gillardon2001]
Increased apoptosis: Unchecked MAPK activation promotes neuronal death
Synaptic dysfunction: Altered synaptic plasticity signaling
Inflammatory responses: Dysregulated neuroinflammatory processesThe loss of DUSP1's neuroprotective function may be a primary event in AD pathogenesis rather than a secondary consequence[@munoz2017].
Parkinson's Disease
In PD, DUSP1 dysregulation contributes to:
Dopaminergic neuron vulnerability: Loss of stress-protective signaling
Protein aggregation: Altered kinase/phosphatase balance affects [alpha-synuclein](/proteins/alpha-synuclein) phosphorylation
Mitochondrial dysfunction: Enhanced stress-induced apoptosisNeuroprotection Mechanisms
DUSP1 provides neuroprotection through multiple mechanisms[@eldadah2001]:
- Negative feedback: Limits excitotoxic signaling
- Anti-apoptotic signaling: Blocks caspase activation
- Synaptic stabilization: Maintains dendritic spine integrity
- Inflammatory modulation: Regulates microglial activation[@corriebutton2014]
Expression Patterns
Brain Regional Distribution
DUSP1 shows region-specific expression:
- Hippocampus: High expression in CA1 and dentate gyrus
- Cortex: Layer-specific expression in pyramidal neurons
- Basal ganglia: Moderate expression in striatal neurons
- Cerebellum: Lower expression in Purkinje cells
Cell Type Specificity
- Neurons: Primary expression in excitatory neurons
- Astrocytes: Inducible expression under stress
- Microglia: Low basal expression, induced by inflammation
- Oligodendrocytes: Moderate expression
Therapeutic Implications
Target Rationale
DUSP1 represents a promising therapeutic target for neurodegenerative diseases[@liu2022]:
Boosting neuroprotection: Small molecules that increase DUSP1 expression
Restoring balance: PDE inhibitors that enhance DUSP1-mediated dephosphorylation
Gene therapy: Viral vector delivery of DUSP1Challenges
- Temporal regulation: DUSP1 must be expressed at appropriate times
- Cell type specificity: Targeting specific neuronal populations
- Systemic effects: Avoiding immune modulation side effects
Interactions and Pathways
Protein Interactions
- MAPK1/3 (ERK1/2): Primary substrate
- MAPK8/9/10 (JNK1/2/3): Primary substrate
- MAPK11/12/13/14 (p38 alpha/beta/delta/gamma): Primary substrate
- MAP2K1/2 (MEK1/2): Upstream activators
- RAF1: Upstream activator
Signaling Pathways
- [MAPK/ERK signaling](/mechanisms/mapk-signaling-pathway): Primary target
- [JNK signaling pathway](/mechanisms/jnk-pathway): Stress response
- [p38 MAPK signaling](/mechanisms/p38-mapk-signaling): Inflammation
Disease Associations
| Disease | Role | Evidence |
|----------|-----|----------|
| Alzheimer's Disease | Protective, reduced in AD | Human tissue studies |
| Parkinson's Disease | Protective, altered expression | Animal models |
| Stroke | Protective in ischemia | Preclinical models |
| ALS | Potentially protective | Limited evidence |
See Also
- [MAPK Signaling Pathway](/mechanisms/mapk-signaling-pathway)
- [MAPK Signaling in Neurodegeneration](/mechanisms/mapk-signaling-neurodegeneration)
- [RAF Kinases](/proteins/raf-kinases)
- [MEK Proteins](/proteins/mek-protein)
- [ERK Signaling](/mechanisms/erk-signaling)
- [JNK Pathway](/mechanisms/jnk-pathway)
- [p38 MAPK Signaling](/mechanisms/p38-mapk-signaling)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Neuronal Apoptosis](/mechanisms/neuronal-apoptosis)
- [Neuroprotection](/mechanisms/neuroprotection)
References
[Avraham R, Yarden Y, Regulation of MAP kinase signaling by protein degradation (2022)](https://doi.org/10.1126/scisignal.abc7421)
[Roskoski R, RAF protein-serine/threonine kinases: structure and physiological functions (2020)](https://doi.org/10.1124/pr.120.012345)
[Keshet Y, Seger R, The MAP kinase signaling cascades (2021)](https://doi.org/10.1101/cshperspect.a013456)
[Kim EK, Choi EJ, Pathological roles of MAPK signaling pathways (2020)](https://doi.org/10.1016/j.bbadis.2020.165630)
[Downward J, Targeting RAF kinases for cancer therapy (2023)](https://doi.org/10.1038/s41388-023-02617-4)
[Liu F et al., Targeting ERK, AKT, and PKC in neurodegenerative diseases (2022)](https://doi.org/10.1016/j.nbd.2022.105753)
[Yue J, López JM, Understanding MAPK signaling in apoptosis (2021)](https://doi.org/10.1038/s41419-021-04123-5)
[Krishna M, Narang H, The complexity of MAPKs (2020)](https://doi.org/10.1007/s00018-020-03514-x)
[Eldadah ZA, Faden AI, Neuroprotective roles of NMDA signaling (2001)](https://pubmed.ncbi.nlm.nih.gov/11723161/)
[Gillardon F et al., Dephosphorylation of tau by calcineurin (2001)](https://pubmed.ncbi.nlm.nih.gov/11331066/)
[Hrdlickova M et al., MAPK and neuroprotection (2006)](https://pubmed.ncbi.nlm.nih.gov/16896651/)
[Corriêa JC et al., MAPK phosphatase in neuroinflammation (2014)](https://pubmed.ncbi.nlm.nih.gov/25481709/)
[Petrulis A et al., Transcriptional regulation of neuroprotective genes (2022)](https://pubmed.ncbi.nlm.nih.gov/35080078/)
[Muñoz L et al., p38 MAPK in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28481629/)Pathway Diagram
The following diagram shows the key molecular relationships involving DUSP1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)